Africa Vaccine
Consortium
We are part of Interdisciplinary Consortium for Epidemic Research(ICER)and the Coalition for Equitable Research in Low Resources Settings(CERCLE)
Research Areas
AFRIVAXn is an African led network with representation in all African regions leveraging on long standing collaboration from global north partners
Research Team
Our research covers all aspects of vaccine research and development, uptake and utilisation by health systems.
Our institutions
MLI has an academic response to epidemics with the noble purpose of improving the health and life of those that need it the most.
Brief overview of AFRIVAXn
AFRIVAXn formerly known as AFRIVAC was founded in 2023 to lead research on vaccines and the associated Research and Development ecosystem. This was informed by limited inclusion of African population in most clinical trials of therapeutics and vaccines
READ MORE
AFRIVAXn
Lead Research on vaccines and associated ecosystem of Research Development.
Lung Institute Building New Upper Mulago Hill Road Makerere University College of Health Sciences
AFRIVAXn runs several programs through its Departments of Education and Training.
P.O Box 7749; Kampala-Uganda
Email: info@afrivaxn.org
Tel: +256414699134
Research Areas
Our research covers all aspects of vaccine research and development, uptake and utilisation by health systems.This includes infectious diseases emerging and re-emerging, non-communicable diseases, and social determinants of health.
READ MORE
Partner Countries
AFRIVAXn is an African led network with representation in all African regions leveraging on long standing collaboration from global north partners
